Another PBM Favors Sandoz And Boehringer On Adalimumab
Humira Rivals Hyrimoz And Cyltezo Get Preferred Status From Express Scripts
• By David Wallace
Express Scripts has awarded preferred status to Sandoz and Boehringer’s biosimilars • Source: Shutterstock 
